{{Rsnum
|rsid=7224837
|Gene=AXIN2
|Chromosome=17
|position=65532005
|Orientation=plus
|GMAF=0.1162
|Gene_s=AXIN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 25.7 | 0.9
| HCB | 71.5 | 26.3 | 2.2
| JPT | 74.3 | 23.0 | 2.7
| YRI | 85.0 | 11.6 | 3.4
| ASW | 75.4 | 21.1 | 3.5
| CHB | 71.5 | 26.3 | 2.2
| CHD | 65.1 | 33.0 | 1.8
| GIH | 90.1 | 9.9 | 0.0
| LWK | 89.1 | 10.0 | 0.9
| MEX | 81.0 | 17.2 | 1.7
| MKK | 90.4 | 9.6 | 0.0
| TSI | 85.3 | 14.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22370446
|Title=Association of AXIN2 with non-syndromic oral clefts in multiple populations
|OA=1
}}

{{PMID Auto
|PMID=24078348
|Title=An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}